Clinical Trial Update: QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating QLC5508 versus standard chemotherapy in pretreated advanced or metastatic esophageal squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Chemotherapy (standard of care) (Chemotherapy)
• QLC5508

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 3 | Status: RECRUITING